A new study shows that lipid nanoparticles restructure their membrane significantly after being absorbed into a cell and ...

Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...

A study from FAU has shown that lipid nanoparticles restructure their membrane significantly after being absorbed into a cell and ending up in an acidic environment. Vaccines and other medicines are ...

Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

Moderna (NasdaqGS:MRNA) is shifting away from self-funding new Phase III vaccine trials in response to increased vaccine hesitancy in the U.S. The company is seeking external partners to finance and ...

Aircraft wing-shaped structures inside tiny channels produce consistent drug delivery particles at any scale, from small laboratory tests to factory production, while substantially cutting costs.

TOKYO, Feb. 2, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million (1) ) in six R&D projects ...

Scientists at KAIST have found a way to turn a tumor’s own immune cells into powerful cancer fighters—right inside the body.

UVA Health scientists are reporting promising success as they pioneer a new way to create vaccines far more quickly, nimbly ...

The Trump administration finalized a new policy on Thursday giving the president the power to fire or discipline as many as 50,000 career federal employees, the latest step in the president’s efforts ...

Investors received 0.05363 BioNTech American Depositary Shares (ADS) for each CureVac share they held. This conversion was applied automatically, even to minority shareholders who did not actively ...